Sha et al. revealed that DANCR knockdown was associated with increased binding of EZH2 on the promoters of CD44 and ABCG2, and concomitant reduction of expression of these genes, suggesting that they may be DANCR targets in triple negative breast cancer 31. This evidence concerns the gene DANCR and triple-negative breast carcinoma.